Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.
Clinical trial NCT00757692 · COMPLETED
Trial details
- NCT number
- NCT00757692
- Sponsor
- British Columbia Cancer Agency
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2012-02-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.